JP2008538923A5 - - Google Patents

Download PDF

Info

Publication number
JP2008538923A5
JP2008538923A5 JP2008509012A JP2008509012A JP2008538923A5 JP 2008538923 A5 JP2008538923 A5 JP 2008538923A5 JP 2008509012 A JP2008509012 A JP 2008509012A JP 2008509012 A JP2008509012 A JP 2008509012A JP 2008538923 A5 JP2008538923 A5 JP 2008538923A5
Authority
JP
Japan
Prior art keywords
nicotinamide riboside
seq
nucleotide sequence
cell
nicotinamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008509012A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008538923A (ja
Filing date
Publication date
Priority claimed from US11/113,701 external-priority patent/US20050227327A1/en
Application filed filed Critical
Publication of JP2008538923A publication Critical patent/JP2008538923A/ja
Publication of JP2008538923A5 publication Critical patent/JP2008538923A5/ja
Pending legal-status Critical Current

Links

JP2008509012A 2005-04-25 2006-04-20 ニコチンアミドリボシドキナーゼ組成物およびその組成物を使用するための方法 Pending JP2008538923A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/113,701 US20050227327A1 (en) 2004-02-10 2005-04-25 Nicotinamide riboside kinase compositions and methods for using the same
PCT/US2006/015495 WO2006116322A2 (en) 2005-04-25 2006-04-20 Nicotinamide riboside kinase compositions and methods for using the same

Publications (2)

Publication Number Publication Date
JP2008538923A JP2008538923A (ja) 2008-11-13
JP2008538923A5 true JP2008538923A5 (https=) 2009-03-19

Family

ID=37215374

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008509012A Pending JP2008538923A (ja) 2005-04-25 2006-04-20 ニコチンアミドリボシドキナーゼ組成物およびその組成物を使用するための方法

Country Status (6)

Country Link
US (1) US20050227327A1 (https=)
EP (1) EP1877068A4 (https=)
JP (1) JP2008538923A (https=)
AU (1) AU2006238858B2 (https=)
CA (1) CA2609633C (https=)
WO (1) WO2006116322A2 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators
EP2805719A1 (en) * 2005-03-30 2014-11-26 Glaxosmithkline LLC Nicotinamide riboside and analogues thereof
US20060292099A1 (en) * 2005-05-25 2006-12-28 Michael Milburn Treatment of eye disorders with sirtuin modulators
US20070149466A1 (en) * 2005-07-07 2007-06-28 Michael Milburn Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders
US20100047177A1 (en) * 2007-01-26 2010-02-25 Washington University Methods and compositions for treating neuropathies
KR101186130B1 (ko) 2010-08-10 2012-09-27 (주)다미화학 니코틴산 아데닌 디뉴클레오티드 인산 또는 그의 유도체를 포함하는 약학적 또는 화장료 조성물
CA2951287A1 (en) 2014-06-06 2015-12-10 Glaxosmithkline Intellectual Property (No. 2) Limited Nicotinamide riboside analogs and pharmaceutical compositions and uses thereof
WO2017004101A1 (en) * 2015-06-29 2017-01-05 The Procter & Gamble Company Skin care compositions comprising particles with nicotinamide riboside and methods of using the same
WO2017004102A1 (en) 2015-06-29 2017-01-05 The Procter & Gamble Company Multi-component skin care product comprising nicoinamide riboside in a multi-chambered container
US20160374918A1 (en) * 2015-06-29 2016-12-29 The Procter & Gamble Company Encapsulated skin care agent
KR102114892B1 (ko) 2016-01-11 2020-05-26 더 프록터 앤드 갬블 캄파니 피부 상태의 치료 방법 및 그를 위한 조성물
CA3045876A1 (en) 2016-11-11 2018-05-17 The Queen's University Of Belfast Scalable syntheses of nicotinoyl ribosides and reduced nic otinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
US11071747B2 (en) 2016-11-29 2021-07-27 University Of Iowa Research Foundation Use of NAD precursors for breast enhancement
MX2019006278A (es) 2016-11-29 2019-08-21 Univ Iowa Res Found Uso de precursores de nad para mejorar la salud materna y/o salud de la descendencia.
CN106755209B (zh) * 2016-12-29 2021-07-23 苏州汉酶生物技术有限公司 一种酶法制备β-烟酰胺单核苷酸的方法
WO2018237218A1 (en) 2017-06-23 2018-12-27 The Procter & Gamble Company COMPOSITION AND METHOD FOR ENHANCING SKIN APPEARANCE
WO2019108873A1 (en) * 2017-12-01 2019-06-06 Elysium Health, Inc. Methods and compositions for treating multiple sclerosis
KR20210011964A (ko) 2018-07-03 2021-02-02 더 프록터 앤드 갬블 캄파니 피부 병태를 치료하는 방법
US10959933B1 (en) 2020-06-01 2021-03-30 The Procter & Gamble Company Low pH skin care composition and methods of using the same
CN115843238B (zh) 2020-06-01 2025-06-10 宝洁公司 改善维生素b3化合物渗透到皮肤中的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1228222A2 (en) * 1999-11-04 2002-08-07 Incyte Genomics, Inc. Human transferase molecules
EP1723227A4 (en) * 2004-02-10 2007-09-19 Dartmouth College NICOTINAMIDRIBOSIDE KINASE COMPOSITIONS AND METHOD FOR THEIR USE
CN1964627B (zh) * 2004-06-04 2011-10-19 华盛顿大学 治疗神经病变的方法和组合物
EP2805719A1 (en) * 2005-03-30 2014-11-26 Glaxosmithkline LLC Nicotinamide riboside and analogues thereof
US20070014833A1 (en) * 2005-03-30 2007-01-18 Sirtris Pharmaceuticals, Inc. Treatment of eye disorders with sirtuin modulators

Similar Documents

Publication Publication Date Title
JP2008538923A5 (https=)
KR102061353B1 (ko) 인간 ezh2의 억제제 및 이의 사용 방법
Gray et al. Control of translation initiation in animals
Hazra et al. Oxidative DNA damage repair in mammalian cells: a new perspective
CN105324483B (zh) 工程化苯丙氨酸解氨酶多肽
Peng et al. Mitochondrial E3 ubiquitin ligase 1: A key enzyme in regulation of mitochondrial dynamics and functions
Spry et al. Coenzyme A biosynthesis: an antimicrobial drug target
Pires et al. Role of RAD51AP1 in homologous recombination DNA repair and carcinogenesis
Kotsinas et al. PIG3: a novel link between oxidative stress and DNA damage response in cancer
TWI716841B (zh) 新穎啟動子及使用該啟動子製造l-胺基酸的方法
CA2598893A1 (en) Eml4-alk fusion gene
Lei et al. N6-methyladenosine (m6A) modification of ribosomal RNAs (rRNAs): Critical roles in mRNA translation and diseases
Vorwerk et al. A transferable plasticity region in C ampylobacter coli allows isolates of an otherwise non‐glycolytic food‐borne pathogen to catabolize glucose
CN114450392A (zh) 工程化为体内产生血清素的先进微生物组疗法
Chang et al. Differences between Cryptococcus neoformans and Cryptococcus gattii in the molecular mechanisms governing utilization of D-amino acids as the sole nitrogen source
AU2019340845B2 (en) Method for producing an antitumoral arenavirus as well as arenavirus mutants
CN117730143A (zh) 通过缀合的n-末端甘氨酸修饰的细胞及其用途
Amodeo et al. Diet suppresses glioblastoma initiation in mice by maintaining quiescence of mutation-bearing neural stem cells
JP2022001048A (ja) B型肝炎治療用組成物、及びb型肝炎ウイルスの複製活性の評価方法
JP2015502137A (ja) E1酵素変異体およびその用途
CN110538179B (zh) Yg1702在制备aldh18a1特异性抑制剂中的应用
KR20180095093A (ko) 뇌 신경 교종 치료용 약물 제조에서의 화합물의 용도
Nicoloff et al. Repression of the pyr operon in Lactobacillus plantarum prevents its ability to grow at low carbon dioxide levels
Jiang et al. KDM4 demethylases: structure, function, and inhibitors
Lee et al. Down syndrome candidate region-1 protein interacts with Tollip and positively modulates interleukin-1 receptor-mediated signaling